{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:17Z","timestamp":1787010017314,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This literature review synthetizes current evidence on the timing and efficacy of dexamethasone intravitreal injections for diabetic macular edema in patients undergoing cataract surgery, particularly phacoemulsification, to determine the optimal timing for improved outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review of the literature was conducted across key databases to identify peer-reviewed studies, clinical trials, and meta-analyses addressing dexamethasone injections administered pre-, intra-, and postoperatively for diabetic macular edema in the context of cataract surgery. Studies were selected based on relevance to timing, visual outcomes, and inflammation control, with a focus on comparative efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The findings suggest that timely dexamethasone injections can substantially reduce inflammation and enhance visual recovery for patients with diabetic macular edema undergoing cataract surgery. Studies indicate that preoperative injections may effectively dampen the inflammatory response triggered by surgical trauma, potentially preserving retinal integrity, whereas intraoperative and postoperative administrations contribute to sustained anti-inflammatory effects during the recovery phase. Comparative studies also highlight dexamethasone's advantages over other anti-inflammatory treatments, such as NSAIDs, particularly in preventing cystoid macular edema. Notably, there was considerable variation in dosage and timing across studies, underscoring the need for standardized treatment protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Dexamethasone intravitreal injections offer a valuable intervention for managing diabetic macular edema in diabetic patients undergoing cataract surgery, with optimal timing playing a crucial role in maximizing therapeutic benefits. Preoperative injections appear to be particularly beneficial in reducing the risk of postoperative inflammatory complications. Further research should focus on developing comprehensive guidelines for timing and dosage to standardize treatment and improve patient outcomes in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004381","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:02:58Z","timestamp":1736438578000},"page":"1030-1042","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["DEXAMETHASONE INTRAVITREAL INJECTION IN DIABETIC PATIENTS UNDERGOING CATARACT SURGERY"],"prefix":"10.1097","volume":"45","author":[{"given":"Alessandro","family":"Meduri","sequence":"first","affiliation":[{"name":"Ophthalmology Clinic, Department of Biomedical Sciences, University of Messina, Messina, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3513-5826","authenticated-orcid":false,"given":"Laura","family":"De Luca","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Biomedical Sciences, University of Messina, Messina, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni William","family":"Oliverio","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Biomedical Sciences, University of Messina, Messina, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Mancini","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Biomedical Sciences, University of Messina, Messina, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letteria","family":"Minutoli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Messina, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Silvagno","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Bergandi","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Aragona","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Biomedical Sciences, University of Messina, Messina, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"608751","DOI":"10.1155\/2010\/608751","article-title":"Diabetic cataract\u2014pathogenesis, epidemiology and treatment","volume":"2010","author":"Pollreisz","year":"2010","journal-title":"J Ophthalmol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4103\/ijo.IJO_1158_17","article-title":"Cataract surgery in diabetes mellitus: a systematic review","volume":"66","author":"Kelkar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/ICU.0000000000000328","article-title":"Management of macular oedema in diabetic patients undergoing cataract surgery","volume":"28","author":"Boscia","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/0974-9233.154389","article-title":"Novel pharmacotherapies in diabetic retinopathy","volume":"22","author":"Dedania","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"582060","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy: vascular and inflammatory disease","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J Diabetes Res"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"953691","DOI":"10.3389\/fphar.2022.953691","article-title":"Diabetic retinopathy: involved cells, biomarkers, and treatments","volume":"13","author":"Ren","year":"2022","journal-title":"Front Pharmacol"},{"key":"R8-20250527","first-page":"25158414211055963","article-title":"The role of inflammation and neurodegeneration in diabetic macular edema","volume":"13","author":"Starace","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jmp5010007","article-title":"Oxidative stress and ROS link diabetes and cancer","volume":"5","author":"Black","year":"2024","journal-title":"J Mol Pathol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"564077","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front Immunol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"2648267","DOI":"10.1155\/2019\/2648267","article-title":"A systematic review and meta-analysis of clinical outcomes of intravitreal anti-VEGF agent treatment immediately after cataract surgery for patients with diabetic retinopathy","volume":"2019","author":"Zhao","year":"2019","journal-title":"J Ophthalmol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1167\/iovs.11-7879","article-title":"Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss","volume":"52","author":"Ly","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.survophthal.2024.07.006","article-title":"Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration","volume":"69","author":"Vujosevic","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"e0214770","DOI":"10.1371\/journal.pone.0214770","article-title":"Analysis of X-ray scattering microstructure data for implementation in numerical simulations of ocular biomechanical behaviour","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/genes12081200","article-title":"Genetics of diabetic retinopathy, a leading cause of irreversible blindness in the industrialized world","volume":"12","author":"Bhatwadekar","year":"2021","journal-title":"Genes"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3390\/ijms24032927","article-title":"Advanced glycation end-products and diabetic neuropathy of the retina","volume":"24","author":"Oshitari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"1055087","DOI":"10.3389\/fimmu.2022.1055087","article-title":"The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications","volume":"13","author":"Yue","year":"2022","journal-title":"Front Immunol"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"973058","DOI":"10.3389\/fendo.2022.973058","article-title":"The role of protein kinase C in diabetic microvascular complications","volume":"13","author":"Pan","year":"2022","journal-title":"Front Endocrinol"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12886-023-03093-y","article-title":"Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery","volume":"23","author":"Lai","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"R23-20250527","first-page":"35","article-title":"Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials","volume":"8","author":"Gao","year":"2021","journal-title":"Eye Vis (London, England)"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.18240\/ijo.2021.10.15","article-title":"Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes","volume":"14","author":"Neves","year":"2021","journal-title":"Int J Ophthalmol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajo.2015.10.005","article-title":"Prevention of cystoid macular edema after cataract surgery in non-diabetic and diabetic patients: a systematic review and meta-analysis","volume":"161","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jcrs.2019.04.025","article-title":"Prevention of macular edema in patients with diabetes after cataract surgery","volume":"45","author":"Laursen","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0975-3583.83035","article-title":"Inflammation and diabetic retinal microvascular complications","volume":"2","author":"Zhang","year":"2011","journal-title":"J Cardiovasc Dis Res"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41598-020-62561-3","article-title":"pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery","volume":"10","author":"Kabanarou","year":"2020","journal-title":"Scientific Rep"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/aos.14516","article-title":"Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study","volume":"99","author":"Fallico","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/IAE.0000000000001234","article-title":"REAL-LIFE study in diabetic macular edema treated with dexamethasone implant: the reldex study","volume":"37","author":"Malcles","year":"2017","journal-title":"Retina"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/11206721211004395","article-title":"Dexamethasone intravitreal implant in patients with cataract and na\u00efve diabetic macular edema","volume":"32","author":"Barone","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ophtha.2012.08.002","article-title":"Dexamethasone intravitreal implant during phacoemulsification","volume":"120","author":"Agarwal","year":"2013","journal-title":"Ophthalmology"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"4896036","DOI":"10.1155\/2017\/4896036","article-title":"Combined phacoemulsification and intravitreal dexamethasone implant (Ozurdex\u00ae) in diabetic patients with coexisting cataract and diabetic macular edema","volume":"2017","author":"Furino","year":"2017","journal-title":"J Ophthalmol"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5301\/ejo.5000920","article-title":"Dexamethasone intravitreal implant at the time of cataract surgery in eyes with diabetic macular edema","volume":"27","author":"Panozzo","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5301\/ejo.5000523","article-title":"Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification","volume":"25","author":"Sze","year":"2015","journal-title":"Eur J Ophthalmol"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IAE.0000000000001552","article-title":"Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery","volume":"38","author":"Calvo","year":"2018","journal-title":"RETINA"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1007\/s12325-020-01506-8","article-title":"Combined intravitreal dexamethasone implant and cataract surgery in patients with diabetic retinopathy: effect on retinal Morphology and function","volume":"37","author":"Minnella","year":"2020","journal-title":"Adv Ther"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IAE.0000000000001552","article-title":"Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery","volume":"38","author":"Calvo","year":"2018","journal-title":"Retina"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/IAE.0000000000002974","article-title":"DIABETIC macular edema and cataract surgery phacoemulsification combined with dexamethasone intravitreal implant compared with standard phacoemulsification","volume":"41","author":"Furino","year":"2021","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:48:41Z","timestamp":1748342921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004381"}},"subtitle":["An Updated Literature Review"],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004381","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}